Study Evaluating SC291 in Subjects With r/r B-cell Malignancies (ARDENT)
Study Evaluating SC291 in Subjects With r/r B-cell Malignancies (ARDENT)
Active, not recruiting · NCT05878184 · Registry updated 2025-10-02Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study Evaluating SC291 in Subjects With r/r B-cell Malignancies (ARDENT) | B-cell chronic lymphocytic leukemia, B-cell neoplasm, Chronic Disease, Disease Attributes, Hemic and Lymphatic Diseases, Leukemia, B-Cell, Lymphoma, B-Cell, Marginal Zone, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, diffuse large B-cell lymphoma, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoma, lymphoproliferative syndrome, mantle cell lymphoma, neoplasm, non-Hodgkin lymphoma | Active, not recruiting | Phase 1 | 2025-10-02 | NCT05878184 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Sana Biotechnology | 5 |
10 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| City of Hope | Duarte | United States | 238 |
| Karmanos Cancer Institute | Detroit | United States | 153 |
| Linear Clinical Research Ltd | Nedlands | Australia | 9 |
| MD Anderson Cancer Center | Houston | United States | 589 |
| Northside Hospital | Atlanta | United States | 134 |
| Peter MacCallum Cancer Centre | Melbourne | Australia | 149 |
| Royal Adelaide Hospital | Adelaide | Australia | 132 |
| Stanford Cancer Institute | Palo Alto | United States | 21 |
| University of Kansas Medical Center | Fairway | United States | 18 |
| University of Nebraska Medical Center | Omaha | United States | 397 |